Robert Half
RHI
$32.76
+8.87%
Robert Half Inc. is a specialized staffing and employment services firm providing temporary, permanent, and outcome-based staffing solutions primarily in finance, accounting, technology, legal, marketing, and administrative fields, operating within the fragmented U.S. staffing industry. The company is a well-established market leader, distinguished by its long operating history since 1948 and its subsidiary Protiviti, which adds a high-value consulting arm focused on technology, risk, and compliance. The current investor narrative centers on the company's resilience and cyclical positioning, with attention on its ability to navigate economic uncertainty impacting hiring demand, as evidenced by recent price volatility, while its consistent dividend payments, as highlighted in recent news, reinforce its appeal to income-focused investors during this period.…
RHI
Robert Half
$32.76
Related headlines
Investment Opinion: Should I buy RHI Today?
Rating: Hold. The core thesis is that RHI presents a high-risk, high-reward opportunity for cyclical investors, but the current price after a 35% 3-month rally already discounts much of the near-term recovery, warranting caution rather than conviction.
Supporting evidence includes the attractive forward P/E of 15.32x based on a projected EPS surge to $2.99, the reasonable price-to-cash-flow of 8.50x, and the solid balance sheet with a 0.33 debt-to-equity ratio. The powerful 3-month momentum of 35.64% indicates buying interest, but the stock remains 23.58% below its year-ago level, highlighting the deep cyclical hole it is climbing out of. The 8.76% dividend yield offers compensation for waiting, though its coverage is currently weak.
The thesis would upgrade to a Buy if the stock pulls back toward the $25-$27 support zone, if quarterly results confirm margin stabilization and progress toward the $2.99 EPS target, or if analyst coverage expands with bullish price targets. It would downgrade to a Sell if the stock fails to hold above $30, if forward EPS estimates are revised downward, or if operating margins deteriorate further below 1.4%. Based on available data, the stock appears fairly valued relative to its projected recovery, but not cheap enough to discount the significant execution risk.
Sign up to view all
RHI 12-Month Price Forecast
The investment case for RHI is balanced on a knife's edge between cyclical recovery and value trap. The valuation is reasonable only if the projected earnings rebound materializes, which is a significant 'if' given current razor-thin margins. The recent explosive rally has likely captured the initial wave of optimism, leaving limited near-term upside without concrete fundamental improvement. The stance is neutral, with a bias to watch for confirmation. An upgrade to bullish would require evidence of sustainable margin improvement in the next quarterly report. A downgrade to bearish would be triggered by a breakdown below the $27 support level or a downward revision to the critical $2.99 EPS estimate.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Robert Half's 12-month outlook, with a consensus price target around $42.59 and implied upside of +30.0% versus the current price.
Average Target
$42.59
3 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
3
covering this stock
Price Range
$26 - $43
Analyst target range
Analyst coverage for Robert Half is limited, with only 3 analysts providing estimates, which is indicative of a mature, mid-cap company that may not command widespread Wall Street attention, potentially leading to less efficient price discovery. The consensus focuses on forward estimates, with an average EPS expectation of $2.99 and revenue of $6.07 billion for the coming year, providing specific fundamental benchmarks but no explicit price target or Buy/Hold/Sell distribution to calculate implied upside or sentiment. The estimated EPS range is tight, from a low of $2.96 to a high of $3.02, signaling strong analyst conviction in the near-term earnings outlook despite the limited coverage; however, without published price targets, the signal strength regarding valuation and potential catalysts or risks remains unclear.
Bulls vs Bears: RHI Investment Factors
The evidence presents a classic battle between cyclical value and operational distress. The bear case is supported by severe margin compression and a long-term downtrend, reflecting fundamental business headwinds. However, the bull case currently holds stronger near-term evidence, anchored by a powerful technical rally from deeply oversold levels, a compelling forward valuation discount anticipating an earnings rebound, and a solid financial foundation. The single most important tension is whether the projected earnings recovery to $2.99 EPS materializes to justify the forward P/E of 15.32x, or if margin pressures persist, making the current valuation a value trap. The resolution of this earnings trajectory will dictate the stock's direction.
Bullish
- Strong Recent Momentum & Oversold Bounce: The stock has surged 35.64% over the past 3 months and 23.01% over the past month, dramatically outperforming the SPY by 20.50% over 3 months. This powerful rally from near its 52-week low of $21.83 suggests a potential trend reversal after a severe -23.58% one-year decline.
- Attractive Forward Valuation & Earnings Recovery: The forward P/E of 15.32x is significantly lower than the trailing P/E of 20.45x, indicating the market is pricing in a substantial earnings recovery. Analyst consensus expects EPS to surge to $2.99 for the coming year from a current trailing EPS of just $0.05, implying a massive projected profit rebound.
- Solid Balance Sheet & Defensive Profile: The company maintains a conservative capital structure with a debt-to-equity ratio of 0.33 and sufficient liquidity with a current ratio of 1.52. Its beta of 0.82 indicates lower volatility than the market, and its consistent dividend (8.76% yield) provides a defensive income cushion during cyclical downturns.
- Reasonable Cash Flow & Asset Valuation: The stock trades at a reasonable price-to-cash-flow multiple of 8.50x and a price-to-sales ratio of 0.51x, suggesting the market is not overpaying for its underlying business assets. The EV/EBITDA of 10.95x further supports a valuation not stretched relative to operating earnings.
Bearish
- Severe Profit Margin Compression: Profitability is under extreme pressure, with a net margin of just 2.47% and an operating margin of only 1.42%. This compression from a gross margin of 37.23% indicates significant operating leverage challenges and cost pressures in the current economic environment for staffing.
- Cyclical Downtrend & Underperformance: The stock remains in a pronounced downtrend, down 23.58% over the past year while the SPY gained 24.99%, resulting in severe underperformance of -48.57%. Trading 26% below its 52-week high of $43.82, it reflects persistent negative sentiment towards the cyclical staffing industry.
- High Short Interest & Skepticism: A short ratio of 12.84 indicates very high short interest and significant market skepticism about the sustainability of the recent rally. This creates a potential overhang and risk of a sharp pullback if the recovery narrative falters.
- Limited Analyst Coverage & Visibility: With only 3 analysts providing estimates, there is limited Wall Street attention and potentially less efficient price discovery. While EPS estimates are tightly clustered, the lack of explicit price targets and broader coverage reduces clarity on catalysts and valuation benchmarks.
RHI Technical Analysis
The stock is in a pronounced downtrend over the past year, with a 1-year price change of -23.58%, and is currently trading near the lower end of its 52-week range, approximately 26% above its 52-week low of $21.83 and 26% below its 52-week high of $43.82. This positioning near the lows suggests the stock is either presenting a deep-value opportunity or remains a 'falling knife' within a broader cyclical decline, heavily underperforming the SPY's 24.99% gain over the same period. Recent momentum shows a significant but volatile recovery, with a 3-month price surge of 35.64% and a 1-month gain of 23.01%, sharply diverging from the negative 1-year trend. This powerful short-term rally, which has generated relative strength of 20.50% against the SPY over 3 months, could signal the early stages of a trend reversal or a substantial bear market rally driven by oversold conditions. Key technical support is firmly established at the 52-week low area around $21.83, while resistance looms near the 52-week high of $43.82; a sustained breakout above the recent recovery highs near $32.50 would be necessary to confirm a new uptrend, while a breakdown below $21.83 would signal a resumption of the primary downtrend. The stock's beta of 0.82 indicates it has been less volatile than the broader market during this turbulent period, which is atypical for a cyclical name and may reflect its defensive dividend characteristics.
Beta
0.82
0.82x market volatility
Max Drawdown
-53.0%
Largest decline past year
52-Week Range
$22-$44
Price range past year
Annual Return
-20.9%
Cumulative gain past year
| Period | RHI Return | S&P 500 |
|---|---|---|
| 1m | +20.8% | -2.9% |
| 3m | +31.9% | +15.0% |
| 6m | +18.2% | +5.6% |
| 1y | -20.9% | +19.1% |
| ytd | +19.8% | +6.9% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
RHI Fundamental Analysis
Revenue trajectory analysis is constrained as specific quarterly revenue and growth rate figures are not available in the provided data; however, analyst estimates for the coming year average $6.07 billion, providing a forward-looking benchmark against which to measure performance. The company's profitability is under significant pressure, with a trailing net margin of just 2.47% and an operating margin of 1.42%, though it remains profitable with a positive EPS of $0.05. The gross margin of 37.23% is a relative strength, but the compression down to the low single-digit operating and net margins indicates substantial operating leverage challenges or cost pressures within the current business environment. Balance sheet health appears solid, with a current ratio of 1.52 indicating sufficient short-term liquidity and a moderate debt-to-equity ratio of 0.33, suggesting a conservative capital structure. The return on equity of 10.42% and return on assets of 1.72% reflect modest but positive returns on capital, while the price-to-cash-flow ratio of 8.50 suggests the market is valuing the company's cash generation at a reasonable multiple given the cyclical headwinds.
Quarterly Revenue
N/A
N/A
Revenue YoY Growth
N/A
YoY Comparison
Gross Margin
N/A
Latest Quarter
Free Cash Flow
N/A
Last 12 Months
Open an Account, get $2 TSLA now!
Valuation Analysis: Is RHI Overvalued?
Given the company's positive net income, the primary valuation metric is the Price-to-Earnings (PE) ratio. The trailing PE is 20.45x, while the forward PE is lower at 15.32x; this gap implies the market expects a meaningful recovery in earnings over the next year, aligning with the observed strong recent price momentum. Compared to sector averages, specific industry benchmark multiples are not provided in the data, preventing a quantified premium/discount analysis; however, a trailing PE of 20.45x for a cyclical staffing firm with compressed margins appears full unless a sharp earnings rebound is imminent. Historical context is also limited due to missing historical ratios data, making it impossible to determine if the current valuation is near the top or bottom of its own historical range; this lack of context adds uncertainty to assessing whether the stock is pricing in optimistic recovery expectations or remains at a value point.
PE
20.4x
Latest Quarter
vs. Historical
N/A
5-Year PE Range 17x~59x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
11.0x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks center on extreme profitability compression. The net margin of 2.47% and operating margin of 1.42% are alarmingly thin, leaving little buffer against further cost increases or revenue declines. The high payout ratio of 179% indicates the dividend is not currently covered by earnings, posing a sustainability risk if earnings do not recover as projected. Revenue concentration in the cyclical U.S. staffing market makes the company highly sensitive to domestic labor demand fluctuations, with forward revenue estimates of $6.07 billion providing a critical benchmark to monitor.
Market & Competitive Risks are heightened by the stock's cyclical nature and valuation uncertainty. While the forward P/E of 15.32x appears reasonable, the lack of sector average and historical multiple data prevents a clear assessment of premium or discount. The stock's beta of 0.82 suggests it has been less volatile than the market, but this defensive characteristic could reverse if economic conditions worsen and staffing demand plummets. The fragmented staffing industry imposes constant competitive pressure on pricing and margins, and any failure to execute the projected earnings rebound could trigger significant multiple compression.
Worst-Case Scenario involves a deepening economic slowdown that crushes temporary staffing demand before the company's earnings can recover. This would lead to consecutive earnings misses, a dividend cut due to the unsustainable payout ratio, and a loss of investor confidence. The realistic downside could see the stock re-test and break below its 52-week low of $21.83, representing a potential loss of approximately -31% from the recent close near $31.60. The historical max drawdown of -54.61% serves as a stark reminder of the stock's vulnerability during severe cyclical downturns.
FAQ
The key risks are, in order of severity: 1) Operational Risk: Extreme profitability compression with a 1.42% operating margin, leaving no room for error. 2) Cyclical/Macro Risk: High sensitivity to U.S. economic health and labor demand, as evidenced by its 23.58% annual decline during market growth. 3) Sentiment Risk: Exceptionally high short interest (ratio 12.84) that can amplify downward moves. 4) Dividend Sustainability Risk: A payout ratio of 179% indicates the dividend is not covered by current earnings, risking a cut if profits don't recover.
The 12-month forecast is bifurcated, with a 50% probability Base Case target range of $32-$36, a 30% probability Bull Case target of $38-$43, and a 20% probability Bear Case target of $22-$26. The Base Case, which is most likely, assumes the company meets the analyst consensus EPS of $2.99 and the forward P/E multiple holds around 15x-18x. The forecast hinges almost entirely on the company's ability to execute the projected earnings recovery; failure to do so would quickly invalidate the Base and Bull cases.
RHI appears fairly valued based on forward earnings expectations but carries significant valuation risk. The trailing P/E of 20.45x is high for a company with 2.47% net margins, but the forward P/E of 15.32x is more reasonable, implying the market expects a major earnings recovery. The price-to-sales of 0.51x and price-to-cash-flow of 8.50x suggest the market is not overpaying for sales or cash generation. Overall, the stock is not clearly overvalued or undervalued; it is priced for a recovery that has yet to be proven, making it a 'show-me' story at current levels.
RHI is a speculative buy for investors with a high risk tolerance and a belief in a near-term economic recovery. The forward P/E of 15.32x offers value if the company hits its $2.99 EPS target, representing significant upside. However, it is not a good buy for conservative investors, as the severe margin compression (1.42% operating margin) and high short interest (ratio 12.84) pose substantial risks. It may be a good buy on a pullback toward $27 for those willing to bet on the cyclical rebound, but entering after a 35% 3-month rally carries timing risk.
RHI is primarily suitable for a medium- to long-term investment horizon (2-3 years minimum) to fully capture a potential cyclical recovery. Its high beta of 0.82 (historically lower than market) and recent volatility make it a poor choice for short-term trading, except for very tactical investors. The high dividend yield of 8.76% provides an income component for longer-term holders, though its sustainability is a concern. Given the need for fundamental earnings improvement, investors should be prepared to hold through quarterly volatility as the recovery story unfolds.